At the conclusion of the session, the participants should be able to:

  • Summarize the recommended evidence-based therapies for children awaiting developmental evaluation or who are previously identified with Autism
  • Outline the eligibility and accessibility of recommended therapies and community-based supports and services.
  • List the state and federal programs available to children with developmental disabilities from birth through transition age
  • Recommend appropriate community resources and services for children with developmental disabilities during clinical practice
Session date: 
06/22/2022 - 12:00pm to 1:00pm CDT
Houston, TX
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.